Back
Amicus Therapeutics Stock Price Chart
Major Market Shift - Act Now Before it's Too Late
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
27
FOLD
Amicus Therapeutics
Last Price:
$7.36
Seasonality Move:
19.56%
7 Day Trial
ALL ACCESS PASS
$
7
This tech company grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
The current trend is relatively stagnant and FOLD is experiencing buying pressure, which is a positive indicator for future bullish movement.
Amicus Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 6.96 | Buy |
| 20-day SMA: | 7.21 | Buy |
| 50-day SMA: | 8.36 | Sell |
| 200-day SMA: | 9.93 | Sell |
| 8-day EMA: | 7.06 | Buy |
| 20-day EMA: | 7.32 | Buy |
| 50-day EMA: | 8.08 | Sell |
| 200-day EMA: | 9.58 | Sell |
Amicus Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.4 | Sell |
| Relative Strength Index (14 RSI): | 46.28 | Sell |
| Chaikin Money Flow: | 3014101 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (6.72 - 8.3) | Sell |
| Bollinger Bands (100): | (8.01 - 9.99) | Sell |
Amicus Therapeutics Technical Analysis
| Apr 11 | Apr 14 | Apr 15 | Apr 16 | Apr 17 | Apr 21 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 11 | 14 | 15 | 16 | 17 | 21 | 22 | 23 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Amicus Therapeutics Stock
Is Amicus Therapeutics Stock a Buy?
-
Amicus Therapeutics share price is 7.35 while FOLD 8-day simple moving average is 6.96, which is a Buy signal.
-
The stock price of FOLD is 7.35 while Amicus Therapeutics 20-day SMA is 7.21, which makes it a Buy.
-
Amicus Therapeutics 50-day simple moving average is 8.36 while FOLD share price is 7.35, making it a Sell technically.
-
FOLD stock price is 7.35 and Amicus Therapeutics 200-day simple moving average is 9.93, creating a Sell signal.
FOLD Technical Analysis vs Fundamental Analysis
Sell
27
Amicus Therapeutics (FOLD)
is a Sell
Is Amicus Therapeutics a Buy or a Sell?
-
Amicus Therapeutics stock is rated a SellThe current Amicus Therapeutics [FOLD] share price is $7.35. The Score for FOLD is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
Amicus Therapeutics Stock Info
Market Cap:
2.3B
Price in USD:
7.35
Share Volume:
3.7M
Amicus Therapeutics 52-Week Range
52-Week High:
12.65
52-Week Low:
6.20
Sell
27
Amicus Therapeutics (FOLD)
is a Sell
Amicus Therapeutics Share Price Forecast
-
What is the Amicus Therapeutics stock price today?The Amicus Therapeutics stock price is 7.35 USD today.
-
Will FOLD stock go up or go down?Amicus Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Amicus Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Amicus Therapeutics is overvalued.
Is Amicus Therapeutics Stock a Buy?
-
Amicus Therapeutics share price is 7.35 while FOLD 8-day exponential moving average is 7.06, which is a Buy signal.
-
The stock price of FOLD is 7.35 while Amicus Therapeutics 20-day EMA is 7.32, which makes it a Buy.
-
Amicus Therapeutics 50-day exponential moving average is 8.08 while FOLD share price is 7.35, making it a Sell technically.
-
FOLD stock price is 7.35 and Amicus Therapeutics 200-day simple moving average is 9.58, creating a Sell signal.
Fundamental Analysis of Amicus Therapeutics
Is Amicus Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.02 per share, an increase this year of $0.27 per share, and an increase next year of $0.33 per share.
Technical Analysis of Amicus Therapeutics
Should I short Amicus Therapeutics stock?
-
FOLD Moving Average Covergence Divergence (MACD) indicator is -0.4, suggesting Amicus Therapeutics is a Sell
-
Amicus Therapeutics Relative Strength Index (RSI) is 46.28, which suggest Amicus Therapeutics is oversold
-
The Bollinger Bands (25) for Amicus Therapeutics is (6.72 - 8.3), which suggest Amicus Therapeutics is a Sell
-
The Bollinger Bands (100) for Amicus Therapeutics is (8.01 - 9.99), which suggest Amicus Therapeutics is a Sell
* Amicus Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.